Bromo Benzyl Cyanide

Bromo Benzyl Cyanide

SCHEMBL437646

N#CC(Br)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 1.00
TSHR P16473 3/20 0.52
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
DPP4 P27487 2/20 0.38
F2 P00734 1/20 0.38
ALDH1A1 P00352 3/20 0.35
HTT P42858 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C1 Q04828 1/20 0.35
MAP2K1 Q02750 1/20 0.35
HTR2A P28223 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
CYP1A1 P04798 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromo Benzyl Cyanide SCHEMBL27315132 1.00 TRPA1 (1.00) TRPA1TSHRCES2CES1DPP4
Bromo Benzyl Cyanide SCHEMBL28184937 0.97 TRPA1 (0.95) TRPA1TSHRCES2CES1DPP4
Bromo Benzyl Cyanide SCHEMBL11220656 0.97 TRPA1 (0.95) TRPA1TSHRCES2CES1DPP4
Bromo Benzyl Cyanide SCHEMBL30600116 0.97 TRPA1 (0.95) TRPA1TSHRCES2CES1DPP4
Bromo Benzyl Cyanide SCHEMBL27879282 0.87 TRPA1 (0.76) TRPA1TSHRCES2CES1ALDH1A1
Bromo Benzyl Cyanide SCHEMBL28327913 0.78 TRPA1 (0.61) TRPA1TSHRALDH1A1LMNASMN1; SMN2
SCHEMBL19734646 0.78 TRPA1 (0.62) TRPA1ALDH1A1HTTL3MBTL1USP2
SCHEMBL4066426 0.77 TRPA1 (0.62) TRPA1TSHRALDH1A1HTTL3MBTL1
SCHEMBL9804339 0.77 TRPA1 (0.60) TRPA1TSHRALDH1A1HTTLMNA
SCHEMBL23451235 0.75 TRPA1 (0.60) TRPA1TSHRCES2CES1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 983 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025106116-A1 LESS-LETHAL PROJECTILES AND CARTRIDGES AND METHODS OF USE AND MANUFACTURE OF THE SAME MCANANY, Yuliya (US) 2025-05-22 WO claimed
CN-116478067-B Cyano-olefin solid luminescent material based on chiral binaphthyl skeleton, and preparation method and application thereof 曲阜师范大学 2024-11-08 CN claimed
CN-117285477-A Synthesis process and device of letrozole 河南康达制药有限公司 2023-12-26 CN claimed
CN-116855100-A Triphenylamine dye capable of being directly used for latent fingerprint development and preparation method and application thereof 青岛科技大学 2023-10-10 CN claimed
CN-115651188-B RAFT chain transfer agent and preparation method and application thereof 南方科技大学 2023-09-05 CN claimed
US-11717532-B2 Methods and compositions for treating wounds utilizing chitosan compounds SYNEDGEN, INC. (US) 2023-08-08 US claimed
CN-116478067-A Cyano-olefin solid luminescent material based on chiral binaphthyl skeleton, and preparation method and application thereof 曲阜师范大学 2023-07-25 CN claimed
CN-111196770-B Simple preparation method of bromfenac sodium 新发药业有限公司 2023-04-07 CN claimed
CN-115651188-A RAFT chain transfer agent, preparation method and application thereof 南方科技大学 2023-01-31 CN claimed
US-20220305051-A1 NITRITE FORMULATIONS AND USES THEREOF FOR THE TREATMENT OF LUNG INJURY UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2022-09-29 US claimed
CN-1626508-A Method for preparing alpha, alpha-dimethyl-4-bromobenzylcyanide SHANGHAI INST OF CHEMICAL REAG (CN) 2005-06-15 CN claimed
WO-2004111185-A2 DIRECT MICRO-PATTERNING OF LIPID BILAYERS USING UV LIGHT AND SELECTED USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2004-12-23 WO claimed
CN-1173938-C Alpha-substitution of unprotected beta-amino ester compounds ���µ�˹ҩ�﹫˾ 2004-11-03 CN claimed
US-20040180147-A1 Direct micro-patterning of lipid bilayers using UV light and selected uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2004-09-16 US claimed
WO-2004025268-A2 OPTICAL BIOSENSORS AND METHODS OF USE THEREOF CARNEGIE MELLON UNIVERSITY (US) 2004-03-25 WO claimed
CN-1334799-A Alpha-substitution of unprotected beta-amino ester compounds AVENTIS PHARM PROD INC (US) 2002-02-06 CN claimed
US-6140508-A USEFUL IN THE PREPARATION OF FARNESYL-PROTEIN TRANSFERASE INHIBITORS. MERCK & CO., INC. (US) 2000-10-31 US claimed
WO-2000001674-A1 PROCESS FOR MAKING 1,5-DISUBSTITUTED IMIDAZOLES MERCK & CO., INC. (US) 2000-01-13 WO claimed
US-5565602-A REACTING A HYDROCARBYL CHLORIDE WITH A CARBONYL SULFIDE AND AMINE IN PRESENCE OF A BASIC CATALYST PHILLIPS PETROLEUM COMPANY (US) 1996-10-15 US claimed
CN-1031252-A Halogenated aromatic base nitrile degrading genes, its cell that uses and contain this gene RHONE POULENC AGROCHIMIE (FR) 1989-02-22 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11717532-B2 Methods and compositions for treating wounds utilizing chitosan compounds CHIA, MMP8, CHIT1 TRPA1 1546/4885TSHR 4714/4885CES2 985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.